ROYAL BANK OF CANADA - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 91 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$2,079,000
-43.6%
13,758
-45.6%
0.00%0.0%
Q2 2022$3,686,000
-22.7%
25,297
-37.1%
0.00%0.0%
Q1 2022$4,770,000
-16.2%
40,231
-2.6%
0.00%0.0%
Q4 2021$5,690,000
+146.2%
41,299
+148.3%
0.00%0.0%
Q3 2021$2,311,000
-13.3%
16,633
-39.5%
0.00%0.0%
Q2 2021$2,667,000
+17.0%
27,474
-17.6%
0.00%0.0%
Q1 2021$2,279,000
-32.7%
33,340
-15.6%
0.00%0.0%
Q4 2020$3,385,000
+192.1%
39,493
+121.6%
0.00%
Q3 2020$1,159,000
-22.2%
17,822
-12.5%
0.00%
-100.0%
Q2 2020$1,489,000
+2657.4%
20,371
+1185.2%
0.00%
Q1 2020$54,000
-90.0%
1,585
-84.1%
0.00%
Q4 2019$542,000
+774.2%
9,949
+578.6%
0.00%
Q3 2019$62,000
-70.8%
1,466
-69.7%
0.00%
Q2 2019$212,000
+1077.8%
4,843
+1264.2%
0.00%
Q1 2019$18,000
+50.0%
355
+13.4%
0.00%
Q4 2018$12,000
-63.6%
313
-65.5%
0.00%
Q3 2018$33,000
+230.0%
908
+227.8%
0.00%
Q2 2018$10,000
+150.0%
277
+87.2%
0.00%
Q1 2018$4,000
+100.0%
148
+94.7%
0.00%
Q4 2017$2,000
-94.1%
76
-91.8%
0.00%
Q3 2017$34,0009250.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 857,494$55,746,00045.68%
RP Management, LLC 2,111,111$137,243,00020.57%
ORACLE INVESTMENT MANAGEMENT INC 2,074,800$134,883,00017.78%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,310,261$85,180,0009.56%
TANG CAPITAL MANAGEMENT LLC 599,091$38,947,0007.05%
Blackcrane Capital, LLC 44,112$2,868,0006.69%
ARS Investment Partners, LLC 559,574$36,378,0005.72%
Eversept Partners, LP 321,581$20,905,9814.64%
Avidity Partners Management LP 1,284,200$83,486,0003.87%
ARDSLEY ADVISORY PARTNERS LP 257,000$16,708,0003.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders